Dysregulation by increased expression or activation of YAP and TAZ have been found to be associated with malignant transformation and oncogenesis in numerous cancers, and thus their regulation (both at the transcriptional and protein levels) has become an area of importance in oncology, especially breast cancer (95–98). The gene discussed is YAP1; the disease is breast carcinoma.